Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90)

Catalog #:   DVV02813 Specific References (0) DATASHEET
Host species: Human
Isotype: IgG1
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DVV02813

Expression system

Mammalian Cells

Species reactivity

Human respiratory syncytial virus A (strain A2)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Applications

Research Grade Biosimilar

Target

F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1

Concentration

2.9 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03420

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

hRSV90

Note

For research use only. Not suitable for clinical or therapeutic use.

Data Image
  • Bioactivity
    Detects Human respiratory syncytial virus A (strain A2) F/Fusion glycoprotein F0 in indirect ELISAs.
  • SDS-PAGE
    Research Grade SDS PAGE for RSV F/Fusion glycoprotein F0 (hRSV90)
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
  • Bioactivity
    Detects HRSV-A2 Pre-F/Fusion glycoprotein F0 Protein in indirect ELISA.
  • Bioactivity
    Detects HRSV Post-F/Fusion glycoprotein F0 Protein in indirect ELISA.
  • Bioactivity
    Detects HRSV F/Fusion glycoprotein F0 Protein in indirect ELISA.
  • Bioactivity
    Figure S5. Binding of a panel of antibodies to DS1, DS2, and PF proteins both pre- and post-conjugation to PC7A/CpG. Antibody binding to DS1, DS2, and PF proteins before (A, C, and E) and after (B, D, and F) conjugation to PC7A/CpG was determined via indirect ELISA. The reactivities of PV2, MPE8, 101F, hRSV90, and 8897 were expressed as EC50 values corresponding to the concentration at which the half-maximum signal was obtained via ELISA, which was based on the optical density at 450 nm.
    Data sourced from citation (PMID: DOI: 10.1002/adfm.202510925)
  • Bioactivity
    Figure 4. 1G9 and 1D8 bind a similar epitope on Pre-F. (A, B) The competitive binding of Nbs 1G9 and 1D8 with six known epitope-specific antibodies. The values are normalized as competitive rates related to the negative control. Data represent the OD450 values measured and are depicted as the mean ± SD from three independent experiments. (C) The values in squares are the percent binding of the monoclonal antibody (IgG) in the presence of the competing Nbs (His-tag) relative to a mock-competition control. Source data are available online for this figure.
    Data sourced from citation (PMID: 41946909)
References
Datasheet
$ 370
Product specifications
100 μg 370 1 mg 1480 5 mg 4440

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90) [DVV02813]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only